Trial intelligence / Profile preview

Praziquantel dose-finding and pharmacokinetic study in opisthorchiasis

ISRCTN77186750Phase 2Completed

Sponsor
Swiss Tropical and Public Health Institute
Start
Aug 2014
Modality
Small Molecules
01

Overview

Phase 2, randomised trial of praziquantel in opisthorchiasis (5 arms), sponsored by Swiss Tropical and Public Health Institute. Primary endpoint: Cure rate. Started Aug 2014; status: completed.

02

Drugs

praziquantel
03

Conditions

opisthorchiasis

Beyond the preview

Go deeper on ISRCTN77186750.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ISRCTN77186750.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call